XORTX Therapeutics Inc. Basic Earnings Loss Per Share From Continuing Operations
XORTX Therapeutics Inc. (XRTX) reported Basic Earnings Loss Per Share From Continuing Operations of -0.17 CAD/shares for the 12-month period ending 2021-12-31, per its 20-F filed 2022-05-03.
Discontinued › Income Statement › Earnings Per Share
ifrs-full:BasicEarningsLossPerShareFromContinuingOperations · last filed 2022-05-03
| Period end | Basic Earnings Loss Per Share From Continuing Operations 12 month |
|---|---|
| 2021-12-31 | -0.17 CAD/shares 20-F · filed 2022-05-03 |
| 2020-12-31 | -0.19 CAD/shares 20-F · filed 2022-05-03 |
| 2019-12-31 | -0.12 CAD/shares 20-F · filed 2022-05-03 |